Might add that my understanding of this whole process of obtaining, developing and getting Evolis to the markets in the first place was a way to negate having to approach rank and file shareholders for any further funds.
This followed on from a less than enthusiastic response by shareholders to an offering some time ago.
I could be wrong but thats the way I see it.